PT3620792T - Processo para diagnóstico in vitro e/ou monitorização de terapia in vitro de uma infecção e/ou doença, em particular doença infecciosa e/ou doença tumoral e/ou doença auto-imune e/ou alergia e/ou para controlo de vacinação e/ou para comprovação de uma proteção cruzada, bem como utilização de um kit num tal processo - Google Patents

Processo para diagnóstico in vitro e/ou monitorização de terapia in vitro de uma infecção e/ou doença, em particular doença infecciosa e/ou doença tumoral e/ou doença auto-imune e/ou alergia e/ou para controlo de vacinação e/ou para comprovação de uma proteção cruzada, bem como utilização de um kit num tal processo

Info

Publication number
PT3620792T
PT3620792T PT191945963T PT19194596T PT3620792T PT 3620792 T PT3620792 T PT 3620792T PT 191945963 T PT191945963 T PT 191945963T PT 19194596 T PT19194596 T PT 19194596T PT 3620792 T PT3620792 T PT 3620792T
Authority
PT
Portugal
Prior art keywords
disease
vitro
allergy
infection
kit
Prior art date
Application number
PT191945963T
Other languages
English (en)
Original Assignee
Genome Identification Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Identification Diagnostics Gmbh filed Critical Genome Identification Diagnostics Gmbh
Publication of PT3620792T publication Critical patent/PT3620792T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT191945963T 2018-08-31 2019-08-30 Processo para diagnóstico in vitro e/ou monitorização de terapia in vitro de uma infecção e/ou doença, em particular doença infecciosa e/ou doença tumoral e/ou doença auto-imune e/ou alergia e/ou para controlo de vacinação e/ou para comprovação de uma proteção cruzada, bem como utilização de um kit num tal processo PT3620792T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102018214872.4A DE102018214872A1 (de) 2018-08-31 2018-08-31 Verfahren zur in vitro Diagnose und/oder in vitro Therapieverfolgung einer Infektion und/oder Krankheit, insbesondere Infektionskrankheit, und/oder Tumorerkrankung und/oder Autoimmunerkrankung und/oder Allergie und/oder zur Impfkontrolle und/oder zum Nachweis einer Kreuzprotektivität sowie Verwendung eines Kits in einem solchen Verfahren

Publications (1)

Publication Number Publication Date
PT3620792T true PT3620792T (pt) 2023-02-07

Family

ID=67874212

Family Applications (1)

Application Number Title Priority Date Filing Date
PT191945963T PT3620792T (pt) 2018-08-31 2019-08-30 Processo para diagnóstico in vitro e/ou monitorização de terapia in vitro de uma infecção e/ou doença, em particular doença infecciosa e/ou doença tumoral e/ou doença auto-imune e/ou alergia e/ou para controlo de vacinação e/ou para comprovação de uma proteção cruzada, bem como utilização de um kit num tal processo

Country Status (6)

Country Link
EP (1) EP3620792B1 (pt)
DE (1) DE102018214872A1 (pt)
DK (1) DK3620792T3 (pt)
ES (1) ES2940130T3 (pt)
PL (1) PL3620792T3 (pt)
PT (1) PT3620792T (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111524613B (zh) * 2020-04-27 2023-05-09 腾讯科技（深圳）有限公司 基于区块链的用户行为轨迹信息采集方法、装置和设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137786A1 (en) * 1993-04-14 1994-10-27 Murex Diagnostics Corporation Immunoassay
JP4148367B1 (ja) * 2007-08-02 2008-09-10 富山県 細胞のスクリーニング方法
GB0815675D0 (en) * 2008-08-28 2008-10-08 Mabtech Ab Antibody secreting cell elispot

Also Published As

Publication number Publication date
EP3620792B1 (de) 2022-12-14
ES2940130T3 (es) 2023-05-03
PL3620792T3 (pl) 2023-04-24
EP3620792A1 (de) 2020-03-11
DK3620792T3 (da) 2023-03-06
DE102018214872A1 (de) 2020-03-05

Similar Documents

Publication Publication Date Title
EP3752242A4 (en) WIRELESS MEDICAL SENSORS AND PROCEDURES
EP3720549A4 (en) PATIENT THERAPY SYSTEMS AND METHODS
EP4104175A4 (en) SYSTEMS AND METHODS AND FOR CALCULATION OF THE TUMOR MUTATION LOAD OF A TARGET PANEL
EP4285917A3 (en) Monoclonal antibodies against her2 epitope and methods of use thereof
EP3056157A3 (en) A medical implant with a proximal rigid fastener and a catheter with a coupling element for interaction with the fastener
MX2018015184A (es) Métodos para el diagnóstico de infecciones bacterianas y virales.
GEP20217263B (en) Anti-cd27 antibodies
DK4000662T3 (da) Kunstigt lungesystem og anvendelsesfremgangsmåder, der ikke udføres på den levende menneske- eller dyrekrop
EP3828598A4 (en) HUMAN BODY DETECTION DEVICE, BED DEVICE AND HUMAN BODY DETECTION SYSTEM
EP3494984A4 (en) TREATMENT AND DIAGNOSIS OF CANCER OR INFECTIOUS DISEASES USING THE DETECTOR MECHANISM OF A T-CELL RECEPTOR
WO2017100540A3 (en) Relaxin immunoglobulin fusion proteins and methods of use
ITUA20162340A1 (it) Sistema per l'immobilizzazione della testa e della zona cervicale di un paziente.
SG11202101578WA (en) Lens for use in a human or animal body, and production methods thereof
PT3620792T (pt) Processo para diagnóstico in vitro e/ou monitorização de terapia in vitro de uma infecção e/ou doença, em particular doença infecciosa e/ou doença tumoral e/ou doença auto-imune e/ou alergia e/ou para controlo de vacinação e/ou para comprovação de uma proteção cruzada, bem como utilização de um kit num tal processo
EP3746066A4 (en) DISEASE DETECTION AND TREATMENT BASED ON TRIMETHYL-LYSINE LEVELS
WO2018013855A3 (en) Il-15/il-15 receptor alpha treatment regimens and use with therapeutic vaccines
IL272094A (en) Antibodies and methods for the diagnosis and treatment of hepatitis B virus infection
EP3931550A4 (en) TISSUE DETECTION SYSTEM AND METHODS OF USE
EP3740755C0 (en) USE OF THE TAS1R3 PROTEIN AS A MARKER FOR THERAPEUTIC, DIAGNOSTIC AND/OR PROGNOSTIC PURPOSES FOR TUMORS EXPRESSING THIS PROTEIN
EP3552014A4 (en) INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND TREATMENT
EP3357996A4 (en) DEVICE FOR THE PRODUCTION OF BIOLOGICAL TISSUE, SYSTEM FOR THE PRODUCTION OF BIOLOGICAL TISSUE AND MEDICAL COST CALCULATION SYSTEM
HK1257598A1 (zh) 改善心臟病變的藥物及其用途
GB201910299D0 (en) Medical uses, methods and uses
GB201907832D0 (en) Medical uses, methods and uses
EP3727422A4 (en) SYSTEM AND METHOD FOR TREATING A DISEASE USING A HYPERSPECIFIC MODIFIED PROTEIN SYSTEM